- Home
- FEBO vs IINN Comparison
FEBO vs IINN Comparison
Compare FEBO & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- IINN
- Stock Information
- Founded
- FEBO 1993
- IINN 2018
- Country
- FEBO Hong Kong
- IINN Israel
- Employees
- FEBO N/A
- IINN N/A
- Industry
- FEBO
- IINN Medical/Dental Instruments
- Sector
- FEBO
- IINN Health Care
- Exchange
- FEBO Nasdaq
- IINN Nasdaq
- Market Cap
- FEBO 12.7M
- IINN 13.7M
- IPO Year
- FEBO 2023
- IINN 2021
- Fundamental
- Price
- FEBO $1.12
- IINN $0.71
- Analyst Decision
- FEBO
- IINN Strong Buy
- Analyst Count
- FEBO 0
- IINN 1
- Target Price
- FEBO N/A
- IINN $2.00
- AVG Volume (30 Days)
- FEBO 7.7K
- IINN 789.6K
- Earning Date
- FEBO 06-17-2025
- IINN 06-13-2025
- Dividend Yield
- FEBO N/A
- IINN N/A
- EPS Growth
- FEBO N/A
- IINN N/A
- EPS
- FEBO N/A
- IINN N/A
- Revenue
- FEBO $17,110,653.00
- IINN N/A
- Revenue This Year
- FEBO N/A
- IINN N/A
- Revenue Next Year
- FEBO N/A
- IINN N/A
- P/E Ratio
- FEBO N/A
- IINN N/A
- Revenue Growth
- FEBO 11.58
- IINN N/A
- 52 Week Low
- FEBO $0.93
- IINN $0.40
- 52 Week High
- FEBO $17.68
- IINN $2.18
- Technical
- Relative Strength Index (RSI)
- FEBO 43.81
- IINN 70.38
- Support Level
- FEBO $1.11
- IINN $0.53
- Resistance Level
- FEBO $1.40
- IINN $0.80
- Average True Range (ATR)
- FEBO 0.12
- IINN 0.08
- MACD
- FEBO -0.03
- IINN 0.03
- Stochastic Oscillator
- FEBO 21.33
- IINN 87.41
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care c principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.